Boston Trust Walden’s Synopsys SNPS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$319K Sell
715
-28
-4% -$13.2K ﹤0.01% 364
2026
Q1
$295K Hold
743
﹤0.01% 362
2025
Q4
$349K Sell
743
-1,704
-70% -$757K ﹤0.01% 352
2025
Q3
$1.21M Sell
2,447
-68
-3% -$38.4K 0.01% 271
2025
Q2
$1.29M Buy
2,515
+41
+2% +$19.1K 0.01% 264
2025
Q1
$1.06M Hold
2,474
0.01% 274
2024
Q4
$1.2M Buy
2,474
+30
+1% +$15.7K 0.01% 274
2024
Q3
$1.24M Buy
2,444
+111
+5% +$59.6K 0.01% 274
2024
Q2
$1.39M Sell
2,333
-114
-5% -$64.5K 0.01% 263
2024
Q1
$1.4M Buy
2,447
+15
+0.6% +$8.26K 0.01% 265
2023
Q4
$1.25M Sell
2,432
-2
-0.1% -$1.02K 0.01% 270
2023
Q3
$1.12M Buy
2,434
+20
+0.8% +$8.95K 0.01% 270
2023
Q2
$1.05M Sell
2,414
-44
-2% -$17.7K 0.01% 277
2023
Q1
$949K Sell
2,458
-976
-28% -$349K 0.01% 281
2022
Q4
$1.1M Buy
3,434
+108
+3% +$33.8K 0.01% 276
2022
Q3
$1.02M Sell
3,326
-32,339
-91% -$10.9M 0.01% 272
2022
Q2
$10.8M Sell
35,665
-45
-0.1% -$13.6K 0.1% 196
2022
Q1
$11.9M Buy
35,710
+2,355
+7% +$735K 0.1% 199
2021
Q4
$12.3M Sell
33,355
-1,100
-3% -$371K 0.1% 204
2021
Q3
$10.3M Buy
34,455
+1,605
+5% +$487K 0.09% 208
2021
Q2
$9.06M Buy
32,850
+8,600
+35% +$2.18M 0.08% 217
2021
Q1
$6.01M Buy
+24,250
New +$6.16M 0.06% 226

Other funds holding SNPS

Boston Trust Walden's SNPS Position: Q2 2026 in Review

Boston Trust Walden reduced its Synopsys (SNPS) stake by 3.8% in Q2 2026, selling an estimated $13.2K and leaving 715 shares worth $319K. The position accounts for ﹤0.01% of the portfolio, ranked #364.

Boston Trust Walden first reported a position in SNPS in Q1 2021 and has held it in 22 quarters since. The position peaked at $12.3M in Q4 2021. 508 funds tracked by Wall St. Rank hold SNPS as of Q2 2026.

  • Boston Trust Walden held 715 shares of Synopsys worth $319K as of Q2 2026.
  • Boston Trust Walden sold 28 Synopsys shares in Q2 2026, an estimated $13.2K.
  • Synopsys made up ﹤0.01% of Boston Trust Walden's portfolio in Q2 2026, its #364 holding.
  • Boston Trust Walden first reported a position in Synopsys in Q1 2021 and has held it in 22 quarters since.
  • Boston Trust Walden's Synopsys position peaked at $12.3M in Q4 2021.
  • 508 funds tracked by Wall St. Rank held Synopsys as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.